Join
Live feed
·
INSIDERFilingvia Quantisnow
Adaptimmune Therapeutics plc logo

New insider Ecor1 Capital, Llc claimed ownership of 164,424,420 units of Ordinary Shares (SEC Form 3)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ADAP (Adaptimmune Therapeutics plc) and more on Quantisnow.